Clinical Trials Logo

Clinical Trial Summary

Incomplete recovery from ischemia causes stunned myocardium. Ischemia may be due to coronary artery disease or aortic cross-clamping during surgery. Stunning leads to myocardial dysfunction. It has been suggested that the mechanism responsible for the contractile depression in stunned myocardium is a decreased sensitivity of the myofibrils to calcium. Levosimendan is a calcium sensitizer, which has been shown to improve the function of stunned myocardium without obvious impairment of diastolic function. Systemic vasodilation and need of vasoconstrictive medication is usually apparent after administration of levosimendan. Colucci et al have demonstrated that with intracoronary administration of milrinone, another inodilator, systemic vasodilation could be excluded. If this is true with levosimendan, it may be possible to improve left ventricular hypo/dyskinesia without afterload reduction by adding levosimendan into cardioplegia solution.

The investigators hypotize that levosimendan, delivered together with cardioplegia, can improve LV dysfunction after opening of aortic cross-clamp in patients undergoing aortic valve and coronary artery bypass operation. Our primary endpoint is a change in cardiac output 15 min after separation from cardiopulmonary bypass compared to the baseline. Secondary endpoints are a change in LV ejection fraction from baseline to 5 min after sternal closure and cTnT/CK-MB on the first postoperative morning.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01500785
Study type Interventional
Source Tampere University Hospital
Contact
Status Terminated
Phase Phase 4
Start date June 15, 2018
Completion date September 11, 2019

See also
  Status Clinical Trial Phase
Withdrawn NCT04830982 - Safety and Efficacy of IV Diazoxide as an Additive to Hyperkalemic Cardioplegia in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass Phase 1
Completed NCT00213746 - Evaluation of Myocardial Viability by Means of Low-dose Dobutamine Gated SPECT (the DOGS Study) N/A
Active, not recruiting NCT00123695 - Serial Echocardiography After Subarachnoid Hemorrhage N/A
Not yet recruiting NCT06308107 - Safety and Feasibility of Hyperkalemic Cardioplegia With Diazoxide in Cardiac Surgery (CPG-DZX) Trial Phase 1
Completed NCT02545426 - Myocardial Stunning During Hemodialysis: Role of Dialyste Calcium Concentration N/A
Completed NCT01179802 - Exercise-induced Changes in Cardiac Function & Morphology N/A
Recruiting NCT04448639 - Stunning in Takotsubo Versus Acute Myocardial Infarction
Withdrawn NCT02770183 - Rate of Left Ventricular Systolic Function's Recuperation After Cardiac Surgery With Extracorporeal Circulation.
Recruiting NCT05669144 - Co-transplantation of Mesenchymal Stem Cell Derived Exosomes and Autologous Mitochondria for Patients Candidate for CABG Surgery Phase 1/Phase 2
Recruiting NCT05209230 - Is Myocardial Stunning Induced by Continuous Renal Replacement Therapy a Reality in Critically Ill Patients? N/A
Withdrawn NCT02687269 - Ranolazine a Potential New Therapeutic Application Phase 4